[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,344,864
  • Shares Outstanding, K 78,883
  • Annual Sales, $ 4,304 M
  • Annual Income, $ 1,059 M
  • EBIT $ 1,406 M
  • EBITDA $ 1,551 M
  • 60-Month Beta 1.55
  • Price/Sales 10.35
  • Price/Cash Flow 37.43
  • Price/Book 28.83

Options Overview Details

View History
  • Implied Volatility 33.32% (+1.69%)
  • Historical Volatility 28.21%
  • IV Percentile 59%
  • IV Rank 43.82%
  • IV High 49.02% on 01/30/26
  • IV Low 21.07% on 08/12/25
  • Expected Move (DTE 12) 0.00 (0.00%)
  • Put/Call Vol Ratio 1.67
  • Today's Volume 8
  • Volume Avg (30-Day) 72
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 2,114
  • Open Int (30-Day) 2,051
  • Expected Range 562.16 to 562.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $3.95
  • Number of Estimates 6
  • High Estimate $4.03
  • Low Estimate $3.81
  • Prior Year $3.63
  • Growth Rate Est. (year over year) +8.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
523.38 +7.41%
on 05/13/26
585.12 -3.92%
on 05/07/26
-0.81 (-0.14%)
since 05/05/26
3-Month
523.38 +7.41%
on 05/13/26
615.47 -8.66%
on 03/06/26
-56.76 (-9.17%)
since 03/05/26
52-Week
506.91 +10.90%
on 07/16/25
769.98 -26.99%
on 11/26/25
+39.95 (+7.65%)
since 06/05/25

Most Recent Stories

More News
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing...

IDXX : 562.16 (-0.46%)
Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?

Although IDEXX Laboratories has lagged the broader market over the past year, Wall Street analysts remain fairly bullish about the company’s long-term growth prospects.

XHE : 80.82 (-0.63%)
$SPX : 7,383.74 (-2.64%)
IDXX : 562.16 (-0.46%)
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Third menu expansion in four years broadens intestinal parasite detection in routine care

IDXX : 562.16 (-0.46%)
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

Built-in SDMA delivers earlier insights with seamless workflow

IDXX : 562.16 (-0.46%)
The Biology Came First.

Over 20 partner-owned drug programs have reached clinical trials as a result of antibody discovery work performed by MindWalk scientists — ten currently in active Phase 1–3. The same scientific depth...

CGEM : 13.51 (-6.38%)
IDXX : 562.16 (-0.46%)
IPA : 2.07 (+7.25%)
ARGX : 891.32 (+5.82%)
XNCR : 11.77 (-2.00%)
HYFT : 1.6800 (-9.19%)
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat at...

IDXX : 562.16 (-0.46%)
Idexx: Q1 Earnings Snapshot

Idexx: Q1 Earnings Snapshot

IDXX : 562.16 (-0.46%)
IDEXX Laboratories Announces First Quarter Results

Achieves first quarter revenue growth of 14% as reported and 11% organic, and CAG Diagnostics recurring revenue growth of 14% as reported and 11% organic. ...

IDXX : 562.16 (-0.46%)
IDEXX Laboratories Set to Reveal Whether Veterinary Diagnostics Momentum Can Justify Premium Valuation

Barchart Research What to Expect from IDXX Earnings IDXX Generated May 4, 2026 Current Price $563.12 EPS Estimate $$3.42 Consensus Rating Moderate Buy Average Move 10.62% IDEXX Laboratories Set to Reveal...

IDXX : 562.16 (-0.46%)
What You Need to Know Ahead of IDEXX Laboratories' Earnings Release

IDEXX Laboratories is ready to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit growth.

XLV : 153.01 (+0.61%)
$SPX : 7,383.74 (-2.64%)
IDXX : 562.16 (-0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 576.03
2nd Resistance Point 572.55
1st Resistance Point 567.35
Last Price 562.16
1st Support Level 558.67
2nd Support Level 555.19
3rd Support Level 549.99

See More

52-Week High 769.98
Fibonacci 61.8% 669.49
Fibonacci 50% 638.45
Fibonacci 38.2% 607.40
Last Price 562.16
52-Week Low 506.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.